Skip to main content
Veterinary Medicines

DOG ECZEMA

Authorised
  • Zinc oxide
  • PRECIPITATED SULPHUR
  • Prednisolone
  • NEOMYCIN SULFATE

Product identification

Medicine name:
ДОГ ЕКЗЕМА
DOG ECZEMA
Active substance:
  • Zinc oxide
  • PRECIPITATED SULPHUR
  • Prednisolone
  • NEOMYCIN SULFATE
Target species:
  • Dog
  • Cat
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Zinc oxide
    3.00
    gram(s)
    /
    100.00
    millilitre(s)
  • PRECIPITATED SULPHUR
    500.00
    milligram(s)
    /
    100.00
    millilitre(s)
  • Prednisolone
    100.00
    milligram(s)
    /
    100.00
    millilitre(s)
  • NEOMYCIN SULFATE
    50000.00
    international unit(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Cutaneous emulsion
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QD07CA03
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Farma Vet OOD
Marketing authorisation date:
Manufacturing sites for batch release:
  • Farma Vet OOD
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-2609
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 13/09/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 13/09/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 13/09/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."